HHS OIG Issues Open Letter On Changes In OIG Civil Fraud Settlement Policies and Practices
Client Alert | 1 min read | 11.21.01
On November 20, 2001, DHHS Inspector General Janet Rehnquist issued an open letter to health care providers announcing changes to certain Office of Inspector General ("OIG") civil settlement policies and practices in response to concerns expressed by providers.
One change is the development of eight criteria to be considered by OIG staff in determining whether, in a given case, it would be appropriate for the OIG to forego administrative exclusion without imposing a corporate integrity agreement or, if a corporate integrity agreement is deemed appropriate, what the substance of the agreement should be. A second change is the modification of the claims review process mandated in future and, where appropriate, existing corporate integrity agreements to require the use of full statistically valid random samples only in cases where an initial claims review has identified an unacceptably high error rate.
The letter also promises that the OIG will explore ways to increase reliance on providers' internal audit capabilities, and will be more flexible in other integrity agreement requirements, such as employee training.
The letter included two attachments further detailing the new claims review procedures: (1) a summary of the procedures; and (2) a list of frequently asked questions regarding the new procedures.
Insights
Client Alert | 5 min read | 08.21.26
FTC Proposes Enforcement Policy Statement on Personalized Pricing: What Businesses Need to Know
On August 19, 2026, the Federal Trade Commission (FTC) announced a proposed Enforcement Policy Statement on personalized pricing — the practice of companies using consumers’ personal data to set individualized prices, discounts, coupons, or other incentives. The proposed statement, which is open for public comment for 30 days following publication in the Federal Register, marks a major step up in the FTC’s focus on data-driven pricing strategies and puts businesses across industries on notice that undisclosed or inadequately disclosed personalized pricing will not be tolerated. Importantly, while the proposed statement is not a binding legal requirement and does not create new legal obligations, it serves as an enforcement warning that the FTC is prepared to use its existing enforcement authority under Section 5 of the FTC Act (Section 5) and is also a potential harbinger of rulemaking. Businesses that engage in — or are considering — personalized pricing should carefully assess their disclosure practices and data collection procedures against the standards articulated in this statement.
Client Alert | 7 min read | 08.19.26
CMS’s Final Rule Bans Federal Medicaid Funding for Youth Gender-Affirming Care
Client Alert | 2 min read | 08.19.26
